Financing
The LTFU studies are commissioned research initiated by Merck & Co, Inc, in response to requirements from the U.S. Food and Drug Administration (FDA).
The LTFU studies are financed by the pharmaceutical manufacturer Merck Sharp & Dohme (MSD) Norway
